PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults
by Mass General Brigham edited by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented […]
PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults Read More »
